Study to Evaluate of EXG34217 in Patients With Telomere Biology Disorders With Bone Marrow Failure
Clinical trial NCT04211714 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04211714
- Sponsor
- Elixirgen Therapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-08
- Primary completion
- 2026-10-08
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.